中文版
Yunnan Kunda Biological Cell Technology Co., Ltd. was founded in 2020. It is a technology-based enterprise integrating multiple businesses such as "stem cell preparation and storage, immune cell preparation and storage, organoid construction, scientific research cooperation services, and health management". KunDa Biological owns an advanced cell technology R&D center and a personalized precision diagnosis and treatment service platform, and has established strict cell quality management standards and a complete scientific research and technical service system. At the same time, it has built cooperation platforms with universities and hospitals such as Fudan University, Kunming Medical University, the First Affiliated Hospital of Kunming Medical University, and the Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital) to jointly promote the clinical transformation research and application of scientific research technologies.
2024年
In 2024, a strategic cooperation was established with
the Management Committee of Dehong Area in
China (Yunnan) Pilot Free Trade Zone.Establish a Tropical Disease Research Institute to carry out innovative pilot projects and priority experience work on cell and gene drugs.
2023年
In 2023, it collaborated with Kunming Medical University to apply for a new-type R&D institution.he Conference Center of the National People's Congress was invited to participate in the Academic Report on Skin - health - focused Precision Dermatology Medicine.
Miao Yukang was interviewed by major media outlets.
2020年
The two parties jointly built a biomedical cell industry demonstration laboratory and a cell bank, developing into a joint community dedicated to transforming scientific research achievements in biotechnology from CAS into industrial applications and facilitating their commercialization.
In 2015 cooperation was carried out with the Chinese Academy of Sciences.The two parties jointly built a biomedical cell industry demonstration laboratory and a cell bank, developing into a joint community dedicated to transforming scientific research achievements in biotechnology from CAS into industrial applications and facilitating their commercialization.
In 2012, Airuikang Medical Investment Management (Beijing) Co., Ltd. was established.It has deeply engaged in eight core fields: stem cell technology, regenerative medicine, gene detection/diagnostic reagents, assisted reproductive medicine, hospital management, health management, medical services, and medical training, aiming to build an influential life and health industry chain.
Email address:kd@kundacell.com
Tel/WeChat：17156961978
Headquarters Address:No. 1168 Chunrong West Road, Yuhua Street,
Chenggong District, Kunming City, Yunnan